AI-based non-invasive profiling of the tumor immune microenvironment using longitudinal CT radiomics predicts immunotherapy response in lung cancer
BackgroundDespite advances in immunotherapy, durable responses in lung cancer remain limited to a subset of patients, underscoring the need for biomarkers capturing spatial immune-tumor interactions. Current methods, such as PD-L1 immunohistochemistry,…